Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.
Full description
The study is to be conducted over the 1st season (September 2024-April 2025) as an effectiveness trial and the 2nd (September 2025-April 2026) as a replication study. This protocol covers the first season. Parents of eligible children who are 6 month-17 year-old who are due for both a COVID-19 and influenza vaccine will be sent text messages. Within each practice site, parents of eligible children will be randomized to receive either: 1) combined COVID-19 and influenza vaccine text message reminders, 2) COVID-19 reminders alone, 3) influenza reminders alone, or 4) no reminders (usual care).
Randomization is to be stratified by practice site, age group and prior year's COVID-19/influenza vaccine history. Messages will be sent centrally and managed by the research team.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Child that:
Receives care at study site
Language listed in electronic health record is English or Spanish
Has not opted out of text messages from practice
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
50,000 participants in 4 patient groups
Loading...
Central trial contact
Alex Fiks, MD MSCE; Melissa Stockwell, MD MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal